Programs

McGill Centre for Translational Research in Cancer

The McGill Centre for Translational Research in Cancer  focuses on the translation of the novel and exciting findings made in the laboratory into testable hypotheses for evaluation in clinical trials.

The Centre provides the infrastructure for investigators involved in translational research to generate novel approaches to cancer treatment, incorporating pre-clinical/mechanistic studies expertise with an excellent site for complex and early phase clinical testing.

The Centre provides two key core functions:

• A Clinical Research Unit. The Unit has an established track record in novel cancer therapeutics, including pharmacokinetics/dynamics, and provides high quality data and patient safety.
• A tissue/tumor bank. The bank contains high quality, clinically derived specimens, carefully preserved for laboratory studies of protein and nucleic acids.

The development of novel therapeutics is extremely expensive, in the discovery stages as well as during pre-clinical and clinical development. The Centre positions its scientists to interact with industry at all stages in the development of a novel therapeutic idea. It facilitates significant technology transfer and commercial agreements while retaining the opportunity to continue in the clinical development program derived from its discoveries.

The McGill University Centre for Translational Research in Cancer is based at the Sir Mortimer B. Davis-Jewish General Hospital. The Centre includes researchers from a wide range of McGill departments, as well as from the Université de Montréal, Institut Armand Frappier, and Université du Québec.

Contact Information
Director:	Dr. Gerald Batist (514) 340-8222 x5418
Administration:	Angie Fragomene (514) 340-8222 x5418